Genedata

What Genedata does

Genedata AG is a Switzerland-headquartered enterprise software company founded in 1997 that develops a unified Biopharma Platform combining a single data model with workflow automation and embedded AI to accelerate discovery, development, and manufacturing of biologics and other therapeutic modalities. The platform is delivered through a suite of integrated modules: Genedata Biologics for biotherapeutics discovery and protein engineering; Genedata Bioprocess for cell line development, upstream/downstream process development, and CMC; Genedata Expressionist for mass spectrometry and Multi-Attribute Method analysis; Genedata Screener for high-throughput assay data analysis (SPR, HT-Flow, HCS, patch clamp); Genedata Selector for NGS-based biosafety and CRISPR workflows; Genedata Profiler for precision medicine; Genedata Chromatics for chromatography; and Genedata Vico, an AI-native CMC platform built on Anthropic's Claude frontier model family.

The company sells quote-based enterprise licenses and SaaS subscriptions to a roster that includes the majority of top-100 global pharmaceutical companies (Pfizer, Novartis, Roche, AstraZeneca, Sanofi, GSK, Merck, J&J, AbbVie, Lilly, Bayer, Boehringer Ingelheim, Takeda, Daiichi-Sankyo, Novo Nordisk) plus biotechnology firms (Amgen, Genmab, Biogen, Gilead, MorphoSys, Immunocore, UCB), CROs/CDMOs (Charles River, Evotec, mAbxience, Syngene), and agricultural biotech (Rijk Zwaan, Ajinomoto). Distribution is primarily direct enterprise field sales with regional offices in Basel, Boston, London, Japan, and Singapore, augmented by technology partnerships with instrument vendors (Bruker, SCIEX, LECO, Sartorius) and co-development alliances with major pharma (AstraZeneca for SPR, Bayer for CLD, top-10 pharma for Vico).

Since August 2024, Genedata has operated as a subsidiary of Danaher Corporation, gaining access to cross-selling across Danaher's life sciences portfolio and the Danaher Business System. Revenue is generated through enterprise software licenses (on-premise perpetual), SaaS subscriptions (notably Genedata Bioprocess), and professional services including Scientific Success and GxP compliance support. Headcount is reported at 51-100 employees, and pricing is not publicly disclosed.

Name

Genedata

Legal name

Genedata AG

Website

https://genedata.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

251–500 employees

Short description

Genedata AG is a Switzerland-based enterprise software company, founded 1997 and owned by Danaher since 2024, that provides a unified Biopharma Platform with embedded AI for biologics discovery, bioprocess development, and CMC workflows. Its modules serve the majority of top-100 global pharma plus biotechs, CROs, CDMOs, and agricultural biotech companies.

Ownership category

akta.pro rank

Product category

Biopharmaceutical R&D Software

NAICS

Computer Systems Design and Related Services (54151), Scientific Research and Development Services (5417)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Biopharma R&D software
• Enterprise bioinformatics platforms
• Drug discovery workflows
• Multi-omics data analysis
• Biologics process development

Headquarters

HQ city

Basel

HQ country

Switzerland

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Enterprise Software Licenses (On-premise): Traditional perpetual license model for on-premises deployment of enterprise software platforms. Customers pay upfront license fees with annual maintenance and support contracts.
2. SaaS Subscriptions: Software-as-a-service subscription model for cloud-hosted deployments. Genedata Bioprocess is specifically noted as a SaaS-based platform. Subscription model enables recurring revenue and regular software updates.
3. Professional Services: Implementation, customization, training, and deployment support services. Includes Scientific Success services and GxP Services for regulatory compliance.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

Genedata develops enterprise software platforms for biopharmaceutical R&D, combining a unified data model with workflow automation and embedded AI to support discovery, development, and manufacturing of biologics and other modalities. Its Genedata Biopharma Platform consists of integrated modules covering biotherapeutics discovery, bioprocess and CMC development, mass spectrometry analysis, assay screening, NGS workflows, precision medicine, and chromatography, sold via on-premises licenses, SaaS subscriptions, and professional services to top global pharmaceutical, biotech, CRO, CDMO, and agricultural biotech customers.

Product overview

Genedata offers a unified Biopharma Platform architecture consisting of multiple integrated product modules. The core platform combines a single, unified data model with workflow automation and embedded AI. Key modules include: Genedata Biologics for biotherapeutics discovery workflows; Genedata Bioprocess for CMC and bioprocess development; Genedata Expressionist for mass spectrometry data analysis; Genedata Screener for assay screening data analysis; Genedata Selector for NGS-based development and biosafety; Genedata Profiler for precision medicine; Genedata Chromatics for chromatography workflows; and Genedata Vico for AI-driven CMC. The platform supports all major therapeutic modalities including antibodies, bispecifics, ADCs, cell therapies, gene therapies, RNA therapies, vaccines, and small molecules. Genedata is a Danaher company headquartered in Basel, Switzerland, founded in 1997.

Differentiator

Problem solved

Functional benefit

Products and services

• Genedata Biopharma Platform

Quantifiable outcome

• Up to 80% of losses from failed batches can be recouped using Genedata Vico AI-native CMC platform
• +4 more outcomes

Named customers36 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature8 records

Partnerships

13 partnerships are on record, tiered flagship, core and minor.

• Top 10 Pharmaceutical Companies (co-development)flagshipStrategic or Co-development Partner · 19 May 2026Genedata Vico AI-native CMC platform co-developed with top 10 pharmaceutical companies. This strategic collaboration ensures the platform addresses real-world CMC challenges and is validated by industry leaders before launch.
• mAbxiencecoreTechnology or Integration · 10 March 2026mAbxience selected Genedata Bioprocess to implement automated, SaaS-based platform for bioprocess data management across its biopharmaceutical CDMO operations.
• BrukercoreTechnology or Integration · 9 February 2026Integration of Genedata Screener with Bruker's biophysics automation platforms (SPR Pro8 Series, timsTOF MALDI PharmaPulse) for data management in high-throughput screening and AI-driven drug discovery workflows.
• ImmunocorecoreTechnology or Integration · 5 September 2024Immunocore adopted Genedata Biologics and Genedata Screener to scale up discovery of novel TCR therapeutics.
• Takara BiocoreTechnology or Integration · 18 August 2024Takara Bio integrated Genedata Expressionist for Genomic Profiling for multi-omics data processing across its regenerative medicine and cell therapy research.
• AGU (Augsburg, Germany)minorStrategic or Co-development Partner · 3 June 2024Partnership for bioprocess automation with German biotech company AGU to advance bioprocess development capabilities.
• MorphoSyscoreStrategic or Co-development Partner · 7 June 2023Expanded collaboration since 2009. Genedata Biologics serves as workflow backbone for MorphoSys antibody discovery programs including Ylanthia, Slonomics, and HuCAL libraries.
• DataHowminorStrategic or Co-development Partner · 13 September 2022Partnership to digitalize bioprocess development and manufacturing through DataHow's process analytics expertise combined with Genedata Bioprocess platform.
• IntelliCyt (Sartorius)coreTechnology or Integration · 17 June 2015Alliance integrating Genedata Screener software with IntelliCyt iQue Screener system for high-throughput flow cytometry screening. First highly scalable HT-Flow cytometry solution for drug discovery.
• Bayer Pharma AGcoreStrategic or Co-development Partner · 17 March 2015Collaboration to develop Cell Line Development (CLD) data platform for automation of mammalian cell line development processes for biopharmaceutical production.
• AstraZenecaflagshipStrategic or Co-development Partner · 29 April 2014Co-developed Genedata Screener for SPR (Surface Plasmon Resonance) data analysis platform. AstraZeneca led standardization and quality improvement of SPR screening workflows.
• AB SCIEX and LECO CorporationcoreTechnology or Integration · 27 June 2013Technology partnership for metabolomics data analysis solution. Combines Genedata Expressionist MSX with AB SCIEX LC/MS and LECO GC/MS technologies to enable comprehensive processing and analysis of metabolomics experimental data.
• Tata Consultancy ServicesminorStrategic or Co-development PartnerParticipated in leadership discussion on digital transformation in Indian pharma industry alongside Dr. Reddy's Laboratories, Sun Pharma, and Matrix Pharma.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• BIOVIA (Dassault Systèmes): BIOVIA is Dassault Systèmes' scientific informatics portfolio covering biologics discovery, bioprocess, and lab informatics. It is the broadest direct competitor to Genedata's enterprise platform across discovery-to-manufacturing workflows in biopharma R&D.
• Dotmatics (Siemens Digital Industries): Dotmatics provides a scientific informatics platform (LIMS, ELN, inventory, biology, chemistry) widely used by pharma and biotech. Acquired by Siemens in 2024, it competes head-on with Genedata across discovery biology and chemistry workflows.
• Benchling: Benchling is a cloud-native R&D platform with strong adoption in biologics, cell therapy, and gene therapy. It targets the same biopharma R&D buyers as Genedata, particularly biotechs, with a more modern UX and faster onboarding model.
• Revvity Signals (formerly PerkinElmer Informatics): Revvity Signals offers TIBCO Spotfire and the Signals scientific data platform used in pharma and biotech discovery and development. It competes with Genedata on analytics, multi-omics, and translational research informatics.
• Sapio Sciences: Sapio Sciences provides a unified lab informatics platform (LIMS, ELN, SDMS) used in biopharma discovery and development. It overlaps with Genedata on biologics and molecular biology workflow management.
• LabVantage Solutions: LabVantage is a LIMS provider with strong biopharma and biobanking deployments. It competes with Genedata's bioprocess and CMC workflows that overlap with regulated laboratory data management requirements.
• ACD/Labs (Advanced Chemistry Development): ACD/Labs specializes in analytical, chemistry, and chromatography data management used in pharma R&D and manufacturing. Its analytical and chromatography solutions overlap with Genedata Expressionist and Genedata Chromatics.

Emerging players

• TetraScience: TetraScience provides a scientific data cloud and AI-native data layer for life sciences R&D and manufacturing. It is an emerging challenger targeting the same AI-readiness and unified data model positioning that Genedata Vico now pursues.
• Scitara: Scitara offers a scientific data connectivity platform for lab instruments and informatics systems in pharma and biotech. It addresses the same instrument-integration and data-flow pain points that underpin Genedata's unified platform.

Others

• IDBS (Danaher): IDBS is a Danaher sister company offering scientific informatics for biologics and process development. It is now a portfolio peer under the same parent as Genedata; the two compete historically but increasingly face co-existence or integration risk.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/genedata
• YouTubeyoutube.com/user/GenedataSoftware
• LinkedInlinkedin.com/company/genedata

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genedata